Big Gain For Bio-Path Holdings, Inc.
Fri 21 Aug 20 at 05:34 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) rocketted at $5.16, a gain of 31%. On Thu 20 Aug 20, BPTH:NASDAQ touched a New 2-Week Low of $3.96. The stock appeared on our News Catalysts scanner on Fri 14 Aug 20 at 07:59 AM in the 'EARNINGS' category. From Thu 06 Aug 20, the stock recorded 10.00% Up Days and 27.27% Green Days
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 63.89%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 30.96%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 30.63%
- ShiftPixy, Inc. (PIXY:NASDAQ), 27.03%
- Velocity Financial, Inc. (VEL:NYSE), 24.88%
- Gridsum Holding Inc. (GSUM:NASDAQ), 24.17%
- Moxian, Inc. (MOXC:NASDAQ), 22%
- Midatech Pharma plc (MTP:NASDAQ), 21.9%
- SPAR Group, Inc. (SGRP:NASDAQ), 19.91%
- The Buckle, Inc. (BKE:NYSE), 18.81%